TCL1A (Gene)

Organism:

Homo sapiens

Synonyms:ENTREZ:8115, HGNC:11648, MIM:186960, NM_001098725, NM_021966, NP_001092195, NP_068801, NR_049726, TCL1 family AKT coactivator A, TCL1, TCL1A, XM_017021676, XM_017021677, XP_016877165, XP_016877166

Omim:OMIM:186960

Id:7569b3e0-ef53-5fd6-b7fb-8d1cd38db80b

Hgnc:HGNC:11648

Entrez:8115

Ensembl:ENSG00000100721

Description:TCL1 family AKT coactivator A

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View TCL1A's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with TCL1A.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using TCL1A.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for TCL1A.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with TCL1A.

Results found

Linked to

	Label	Description
	GSE115384 CELSR2 knockdown 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE115384 CELSR2 knockdown 2 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 15 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE159209 artemisinin stem cell 3 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE94849 7 V 5 PINOMETOSTAT HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE120612 etoposide leukocyte 4 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 13 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434,GSE202438 15 V 1 TALAZOPARIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE95077 amiloride 5 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS

GSE115384 CELSR2 knockdown 2 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE115384 CELSR2 knockdown 2 v 7 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 15 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE159209 artemisinin stem cell 3 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE94849 7 V 5 PINOMETOSTAT HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 2 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE120612 etoposide leukocyte 4 v 5 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 13 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE202434,GSE202438 15 V 1 TALAZOPARIB HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE95077 amiloride 5 v 4 human up

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.